课题基金 / 基金详情

NMR STRUCTURES OF PLATELET FACTOR 4 & B-THROMBOGLOBULIN

NMR STRUCTURES OF PLATELET FACTOR 4 & B-THROMBOGLOBULIN
血小板因子 4 的 NMR 结构
批准号:
3361746
负责人:
KEVIN H. MAYO
金额:
$11.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-04-01 至 1993-03-31

项目摘要

项目成果

KEVIN H. MAYO的其他基金

相似基金

相关文献

中文摘要
翻译
血小板因子(PF4)和b -血栓球蛋白相关蛋白(BTG)低
英文摘要
Platelet factor (PF4) and B-thromboglobulin-related proteins (BTG) are low- molecular weight heparin binding proteins generally considered to be platelet specific and are involved in blood clotting, wound healing, tissue repair and cell proliferation. PF4 is known to strongly bind heparin thereby inhibiting the formation of thrombin-antithrombin III complexes at vascular sites. Other physiological activities of PF4 include stimulation of fibroblast attachment to the substrate, stimulation of histamine release from human basophils, chemotactic activity, and potentiation of platelet aggregation. While BTG is about 50% sequentially homologous to PF4, its anti-heparin activity is less, and it possesses significant mitogenic activity in certain cell types and inhibits the catalytic effect heparin on Factor Xa neutralization by anti-thrombin IIIa more than does PF4. Although the structures of PF4 and BTG are considered critical to biological function, little is known about their structure-function, relationships, about how their conformations are related, or about any specific structural domain(s) essential for interaction with heparin or glycosaminoglycans in general. The immediate goal of this project is to elucidate the solution structures of PF4 and low affinity-Pf4 (LA-PF4, the parent protein of the more commonly known BTG), and the long range goal is to identity the protein- heparin binding domain(s). Comparison of PF4 and BTG structures will give initial insight into this latter point. The primary technique to be used towards these goals is high-resolution, two-dimensional proton NMR spectroscopy in combination with computer modeling studies. By using COSY- like and NOESY NMR experiments, sequence-specific proton resonance assignments will be made for PF4 and BTG at low ph under conditions where these proteins exist as monomers (7,800 daltons). NOESY experiments will then be used to establish distance tetrameric structures at low ph than at more physiological conditions will be investigated by NMR methods just described. The tight association of four, tetrahedral-related, identical monomers makes structural elucidation of the 32 kD tetramer feasible by NMR methods.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Secondary structure of neutrophil-activating peptide-2 determined by 1H-nuclear magnetic resonance spectroscopy.
通过 1H 核磁共振波谱测定中性粒细胞激活肽-2 的二级结构。
DOI: 10.1042/bj3040371
发表时间: 1994
期刊: The Biochemical journal
影响因子: --
作者: [Mayo,KH, Yang,Y, Daly,TJ, Barry,JK, LaRosa,GJ]
通讯作者: LaRosa,GJ
Effect of low molecular weight aliphatic alcohols and related compounds on platelet factor 4 subunit association.
低分子量脂肪醇和相关化合物对血小板因子 4 亚基关联的影响。
DOI: --
发表时间: 1993
期刊: The Journal of biological chemistry
影响因子: --
作者: [Yang,Y, Barker,S, Chen,MJ, Mayo,KH]
通讯作者: Mayo,KH
Alcohol-induced protein folding transitions in platelet factor 4: the O-state.
酒精诱导血小板因子 4 中的蛋白质折叠转变:O 状态。
DOI: 10.1021/bi00084a038
发表时间: 1993
期刊: Biochemistry
影响因子: 2.9
作者: [Yang,Y, Mayo,KH]
通讯作者: Mayo,KH
Low-affinity platelet factor 4 1H NMR derived aggregate equilibria indicate a physiologic preference for monomers over dimers and tetramers.
低亲和力血小板因子 4 1H NMR 得出的聚集体平衡表明单体相对于二聚体和四聚体的生理偏好。
DOI: 10.1021/bi00218a007
发表时间: 1991
期刊: Biochemistry
影响因子: 2.9
作者: [Mayo,KH]
通讯作者: Mayo,KH
Designed Antibiotic Peptides and Mimetics
  • 批准号:
    7700374
  • 项目类别:
  • 资助金额:
    $499.56万
  • 财政年份:
    2008
  • 负责人:
    KEVIN H. MAYO
  • 依托单位:
32 processor SGI Onyx 3800 w/64 GB memory and 1 TB disk
  • 批准号:
    6503167
  • 项目类别:
  • 资助金额:
    $91.8万
  • 财政年份:
    2003
  • 负责人:
    KEVIN H. MAYO
  • 依托单位:
Dibenzofuran-based Anginex Mimetics that Target Galectin-1
  • 批准号:
    7477905
  • 项目类别:
  • 资助金额:
    $29.91万
  • 财政年份:
    2002
  • 负责人:
    KEVIN H. MAYO
  • 依托单位:
Peptide Based Antiagiogenic Antitumor Agent
  • 批准号:
    6710598
  • 项目类别:
  • 资助金额:
    $29.13万
  • 财政年份:
    2002
  • 负责人:
    KEVIN H. MAYO
  • 依托单位:
海外基金